Research and Development

Showing 15 posts of 9594 posts found.

Andrew Sandham, executive chairman, Syntaxin

October 20, 2009 Research and Development appointment, appointments, research and development, syntaxin

Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …
Cellectis Sylvie

Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications

October 20, 2009 Research and Development appointment, cellectis, research and development

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …
Blog footer

Digital Pharma: Raising awareness of clinical trials

October 20, 2009 Medical Communications, Research and Development CRO, Quintiles, digi, digital pharma, digital research, patient recruitment

Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …

GSK kidney cancer drug approved in US

October 20, 2009 Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

First details emerge of Pfizer site closures

October 20, 2009 Research and Development, Sales and Marketing MA, Pfizer, restructure

 The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …

Cambridge biotech – innovation and global partnerships

October 19, 2009 Research and Development Cambridge, ERBI, biotech, regenerative medicine

Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …
LisaRojkjaer100

Dr Lisa Rojkjaer, head of clinical development, MorphoSys

October 15, 2009 Research and Development appointment, morphosys, research and development

MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …

GSK plans

October 14, 2009 Research and Development GSK

GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …

Merck makes Indian bioscience acquisition

October 14, 2009 Research and Development Asia, India, Merck

 Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …

GSK’s Avodart tackles BPH better in combination

October 14, 2009 Research and Development, Sales and Marketing GSK, bph, urology

GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …

Contract research news in brief

October 13, 2009 Research and Development CRO

Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …

Head-to-head trial favours Shire’s Fosrenol

October 8, 2009 Research and Development, Sales and Marketing fosrenol, renal

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …

GSK: Committed to improving UK clinical research

October 6, 2009 Research and Development GSK, GlaxoSmithKline, NHS

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …

Contract research news in brief

October 6, 2009 Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …

AZ signs biomarker research deal

October 5, 2009 Research and Development AZ, Cancer

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …
The Gateway to Local Adoption Series

Latest content